Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.41 |
| ▸ | PPARG | P37231 | 6/20 | 0.40 |
| ▸ | PPARD | Q03181 | 6/20 | 0.40 |
| ▸ | PPARA | Q07869 | 6/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | TLR2 | O60603 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | FABP4 | P15090 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15055935 | 1.00 | TSHR (0.48) | TSHRLMNANFKB1PMP22CYP2C19 | |
| SCHEMBL8432144 | 0.98 | CYP2C19 (0.47) | TSHRLMNANFKB1PMP22CYP2C19 | |
| SCHEMBL251210 | 0.96 | CYP2C19 (0.50) | TSHRLMNANFKB1PMP22CYP2C19 | |
| SCHEMBL278372 | 0.96 | CYP2C19 (0.50) | TSHRLMNANFKB1PMP22CYP2C19 | |
| Adipic Acid SCHEMBL2227837 | 0.96 | CYP2C19 (0.50) | TSHRLMNANFKB1PMP22CYP2C19 | |
| SCHEMBL249976 | 0.96 | CYP2C19 (0.50) | TSHRLMNANFKB1PMP22CYP2C19 | |
| SCHEMBL9437316 | 0.96 | CYP2C19 (0.50) | TSHRLMNANFKB1PMP22CYP2C19 | |
| Adipic Acid SCHEMBL4555700 | 0.96 | CYP2C19 (0.50) | TSHRLMNANFKB1PMP22CYP2C19 | |
| SCHEMBL277753 | 0.94 | CYP2C19 (0.53) | TSHRLMNANFKB1PMP22CYP2C19 | |
| SCHEMBL278033 | 0.94 | CYP2C19 (0.53) | TSHRLMNANFKB1PMP22CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11787918-B2 | Biobased compositions | Evoco Limited (CA) | 2023-10-17 | — | — | US | claimed |
| US-11072694-B1 | Biobased compositions | Evoco Limited (CA) | 2021-07-27 | — | — | US | claimed |
| US-20240109998-A1 | POLYURETHANE ELASTOMER COMPOSITION COMPRISING LIGNIN | Evoco Limited (CA) | 2024-04-04 | — | — | US | disclosed |
| US-11905359-B2 | Polyurethane elastomers, bio-additive compositions | Evoco Limited (CA) | 2024-02-20 | — | — | US | disclosed |
| US-11787918-B2 | Biobased compositions | Evoco Limited (CA) | 2023-10-17 | — | — | US | disclosed |
| US-20230101431-A1 | THREE-DIMENSIONAL PRINTING DEVICE FOR PRINTING POLYURETHANE ARTICLES | Evoco Limited (CA) | 2023-03-30 | — | — | US | disclosed |
| US-20220195182-A1 | PLASTICIZER LIGNIN COMPOSITIONS | EVOCO LTD. (CA) | 2022-06-23 | — | — | US | disclosed |
| US-11072694-B1 | Biobased compositions | Evoco Limited (CA) | 2021-07-27 | — | — | US | disclosed |
| US-10934385-B1 | Polyurethane elastomers, bio-additive foam compositions | EVOCO LTD. (CA) | 2021-03-02 | — | — | US | disclosed |
| US-10934384-B1 | Polyurethane elastomer compositions, and processes thereof | EVOCO LTD. (CA) | 2021-03-02 | — | — | US | disclosed |
| US-20150197668-A1 | POLYESTER PROCESSES | XEROX CORPORATION (US) | 2015-07-16 | — | — | US | disclosed |
| US-8574803-B2 | Toner compositions of biodegradable amorphous polyester resins | XEROX CORPORATION (US) | 2013-11-05 | — | — | US | disclosed |
| US-20130164668-A1 | TONER COMPOSITIONS OF BIODEGRADABLE AMORPHOUS POLYESTER RESINS | XEROX CORPORATION (US) | 2013-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11072694-B1 | Biobased compositions | SORD, SCD, ACMSD | TSHR 4843/4885LMNA 713/4885NFKB1 1076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.